-
Taltirelin Acetate: Applied Research Workflows
2026-09-02
Taltirelin acetate supports mechanism-driven studies spanning dopaminergic neuroprotection, pruritus, sleep-related research, and oral formulation testing. This guide connects the reference Parkinson’s disease findings with practical assay design, formulation controls, and troubleshooting strategies.
-
Lovastatin Workflow for HMG-CoA Reductase Studies
2026-09-01
Build mechanism-focused Lovastatin experiments for cholesterol metabolism, cancer research, macrophage efferocytosis, and fibroblast biology. This guide combines concentration planning, pathway-aware controls, assay selection, and troubleshooting with a practical interpretation of recent meristem research.
-
DAPT (GSI-IX) in FOXN1 iTEC Programming
2026-09-01
DAPT (GSI-IX) provides a mechanistic way to interrogate how Notch inhibition shapes FOXN1-driven thymic epithelial cell programming. This guide translates a 2024 Development study into practical assay-design decisions, controls, and interpretation strategies.
-
Redox-Responsive Peptide Coacervates for mRNA Delivery
2026-08-31
Ren and colleagues developed HBpep-SS4, a single-component peptide coacervate that combines mRNA encapsulation with glutathione-responsive intracellular release. The system supported diverse RNA cargos and functional genome editing, while its redox-triggered disassembly offers a mechanistically distinct alternative to conventional lipid-based delivery.
-
CHI3L1-IN-5: Neuroinflammation Workflows
2026-08-31
CHI3L1-IN-5, also called Compound Z17, supports mechanism-first studies of CHI3L1 signaling, astrocyte Aβ handling, and lysosomal recovery. Its CNS-oriented physicochemical profile makes it especially useful for paired inflammatory and cellular-function assays rather than single-endpoint screening.
-
Exercise-Induced Muscle EVs Clear Aβ in AD Mice
2026-08-30
A 2026 Nature Aging study identifies skeletal muscle-derived extracellular vesicles as a molecular link between swimming exercise and improved cognition in Alzheimer’s disease mice. The work shows that miR-378a-3p cargo reprograms disease-associated microglia toward more effective amyloid-β plaque clearance, suggesting an exercise-mimicking therapeutic direction.
-
DAPT (GSI-IX): γ-Secretase Research Guide
2026-08-29
DAPT, also called GSI-IX, is a selective γ-secretase inhibitor used to study amyloid precursor protein processing and the Notch signaling pathway. Product data report nanomolar cellular activity, while application-specific results support its use as a research tool rather than a clinical treatment.
-
Benzyl Quinolone Carboxylic Acid (BQCA) Workflow
2026-08-28
Benzyl Quinolone Carboxylic Acid (BQCA) enables selective M1 receptor potentiation for dose–response, biased-signaling, neuronal activity, and Alzheimer’s disease research. This workflow combines concentration-shift analysis with time-resolved BRET and practical troubleshooting to separate receptor potency, efficacy, and downstream pathway preference.
-
(R,S)-Anatabine: From Mechanism to Translation
2026-08-28
A mechanistic and translational framework for evaluating (R,S)-Anatabine as an amyloid and inflammatory pathway research tool in Alzheimer’s disease models.
-
H 89 2HCl: From PKA Tool to Translational Insight
2026-08-27
A thought-leadership guide to using H 89 2HCl for causal interrogation of cAMP/PKA/CREB signaling, with experimental safeguards, translational context, and a practical osteoclast-focused workflow.
-
Bufuralol Hydrochloride in Human PK Assays
2026-08-27
Bufuralol hydrochloride is a non-selective β-adrenergic receptor antagonist suited to carefully controlled cardiovascular and pharmacokinetic research. This article explains how hiPSC-derived intestinal organoids can add human-relevant exposure context without overstating what the model can prove.
-
Diclofenac in Reliable Cell and Organoid Assays
2026-08-26
Learn how Diclofenac (SKU B3505) can be integrated into cell viability, proliferation, cytotoxicity, and intestinal organoid workflows without confusing assay artifacts with biological effects. This scenario-based guide covers solvent control, stock preparation, endpoint interpretation, and evidence-based product selection.
-
hiPSC Intestinal Organoids for Pharmacokinetic Studies
2026-08-26
Saito and colleagues established a streamlined 3D culture strategy for generating expandable intestinal organoids from human induced pluripotent stem cells. The resulting organoids can be cryopreserved, expanded, and converted into epithelial monolayers containing metabolically functional enterocytes, creating a human-relevant platform for studying intestinal drug absorption, transport, and metabolism.
-
Obeticholic Acid Workflows for FXR Liver Research
2026-08-25
Obeticholic Acid offers a receptor-proximal way to connect FXR activation with bile acid transport, metabolic signaling, and fibrosis-related phenotypes. This practical workflow covers hepatocyte assays, translational liver models, portal hypertension research, and troubleshooting for reproducible experiments.
-
N-MYC–eIF4G1 Survival Axis in inv(16) AML
2026-08-25
Peramangalam et al. identify an N-MYC–eIF4G1 regulatory axis that supports survival in inv(16) acute myeloid leukemia. By combining transcriptomic analysis, enhancer studies, functional perturbation, and patient-derived xenograft experiments, the study connects CBFβ-SMMHC-driven transcriptional deregulation to translational control and leukemic maintenance.